Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial

Acta Ophthalmologica

Volumn 89, Issue 8, 2011, Pages 749-754

  Heijl, Anders ^a   Leske, M Cristina ^b   Hyman, Leslie ^b   Yang, Zhongming ^b   Bengtsson, Boel ^a  

^a LUND UNIVERSITY   (Sweden)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

glaucoma; intraocular pressure; reduction; therapy; treatment effects

Indexed keywords

BETAXOLOL;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE REDUCTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFRACTION ERROR; SEX DIFFERENCE; TRABECULOPLASTY; VISUAL FIELD DEFECT;

AGED; ANTIHYPERTENSIVE AGENTS; BETAXOLOL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASERS, GAS; MALE; MIDDLE AGED; TONOMETRY, OCULAR; TRABECULECTOMY; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 82155166424     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01852.x     Document Type: Article

References (30)

1. Ang GS, Kersey JP, Shepstone L, &, Broadway DC, (2008): The effect of travoprost on daytime intraocular pressure in normal tension glaucoma: a randomised controlled trial. Br J Ophthalmol 92: 1129-1133.
2. Asman P, &, Heijl A, (1992): Glaucoma Hemifield Test. Automated visual field evaluation. Arch Ophthalmol 110: 812-819.
3. Cantor L, (2003): Achieving low target pressures with today's glaucoma medications. Surv Ophthalmol 48 (Suppl. 1): S8-S16. (Pubitemid 41126690)
4. Chung PY, Schuman JS, Netland PA, Lloyd-Muhammad RA, &, Jacobs DS, (1998): Five-year results of a randomized, prospective, clinical trial of diode vs argon laser trabeculoplasty for open-angle glaucoma. Am J Ophthalmol 126: 185-190. (Pubitemid 28397090)
5. Coleman AL, &, Miglior S, (2008): Risk factors for glaucoma onset and progression. Surv Ophthalmol 53 (Suppl. 1): S3-S10.
6. Collaborative Normal-Tension Glaucoma Study Group (1998): The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126: 498-505.
7. European Glaucoma Society (2008): European Glaucoma Society. Terminology andf guidelines for glaucoma. Savona. Editrice Dogam S.r.l.: Pages.
8. Gordon MO, &, Kass MA, (1999): The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol 117: 573-583. (Pubitemid 29218422)
9. Heijl A, Leske MC, Bengtsson B, Hyman L, &, Hussein M, (2002): Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120: 1268-1279. (Pubitemid 36105431)
10. Heijl A, Leske MC, Bengtsson B, &, Hussein M, (2003): Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand 81: 286-293. (Pubitemid 36806269)
11. Heijl A, Bengtsson B, Chauhan BC, Lieberman MF, Cunliffe I, Hyman L, &, Leske MC, (2008): A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology 115: 1557-1565.
12. Jampel HD, (1997): Target pressure in glaucoma therapy. J Glaucoma 6: 133-138. (Pubitemid 27183198)
13. Juzych MS, Chopra V, Banitt MR, Hughes BA, Kim C, Goulas MT, &, Shin DH, (2004): Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 111: 1853-1859. (Pubitemid 39311836)
14. Kass MA, Heuer DK, Higginbotham EJ, et al., (2002): The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120: 701-713. (Pubitemid 34620348)
15. Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, &, Menage MJ, (1992): Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 99: 1499-1504.
16. Law SK, (2009): Switching within glaucoma medication class. Curr Opin Ophthalmol 20: 110-115.
17. Leske MC, Connell AM, Wu SY, Hyman LG, &, Schachat AP, (1995): Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol 113: 918-924.
18. Leske MC, Heijl A, Hyman L, &, Bengtsson B, (1999): Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106: 2144-2153. (Pubitemid 30194238)
19. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, &, Yang Z, (2007): Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114: 1965-1972. (Pubitemid 350016362)
20. Mao AJ, Pan XJ, McIlraith I, Strasfeld M, Colev G, &, Hutnik C, (2008): Development of a prediction rule to estimate the probability of acceptable intraocular pressure reduction after selective laser trabeculoplasty in open-angle glaucoma and ocular hypertension. J Glaucoma 17: 449-454.
21. Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, &, Adamsons I, (2002): The European glaucoma prevention study design and baseline description of the participants. Ophthalmology 109: 1612-1621. (Pubitemid 35006392)
22. Mills KB, Jacobs NJ, &, Vogel R, (1988): A study of the effects of four concentrations of D-timolol, 0.25% L-timolol, and placebo on intraocular pressure on patients with raised intraocular pressure. Br J Ophthalmol 72: 469-472.
23. Musch DC, Lichter PR, Guire KE, &, Standardi CL, (1999): The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 106: 653-662. (Pubitemid 30194301)
24. Musch DC, Gillespie BW, Niziol LM, Cashwell LF, &, Lichter PR, (2008): Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 115: 927-933. (Pubitemid 351749685)
25. Odberg T, &, Sandvik L, (1999): The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand 77: 176-181. (Pubitemid 29164057)
26. Parrish RK II, (2006): The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results? Curr Opin Ophthalmol 17: 138-141. (Pubitemid 43790809)
27. Richardson LE, (1992): Argon laser trabeculoplasty: a review. J Am Optom Assoc 63: 252-256.
28. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, &, Singh K, (1991): Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 109: 1090-1095.
29. Suh MH, Park KH, &, Kim DM, (2009): Effect of travoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma. Jpn J Ophthalmol 53: 18-23.
30. The Advanced Glaucoma Intervention (AGIS) Study Group (1994): The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials 15: 299-325.